- Home
- CELC vs BGR Comparison
CELC vs BGR Comparison
Compare CELC & BGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- BGR
- Stock Information
- Founded
- CELC 2011
- BGR 2004
- Country
- CELC United States
- BGR United States
- Employees
- CELC N/A
- BGR N/A
- Industry
- CELC Medical Specialities
- BGR Trusts Except Educational Religious and Charitable
- Sector
- CELC Health Care
- BGR Finance
- Exchange
- CELC Nasdaq
- BGR Nasdaq
- Market Cap
- CELC 327.3M
- BGR 338.6M
- IPO Year
- CELC 2017
- BGR N/A
- Fundamental
- Price
- CELC $10.15
- BGR $12.50
- Analyst Decision
- CELC Strong Buy
- BGR
- Analyst Count
- CELC 6
- BGR 0
- Target Price
- CELC $30.17
- BGR N/A
- AVG Volume (30 Days)
- CELC 190.9K
- BGR 73.3K
- Earning Date
- CELC 05-14-2025
- BGR 01-01-0001
- Dividend Yield
- CELC N/A
- BGR 6.02%
- EPS Growth
- CELC N/A
- BGR N/A
- EPS
- CELC N/A
- BGR 0.69
- Revenue
- CELC N/A
- BGR N/A
- Revenue This Year
- CELC N/A
- BGR N/A
- Revenue Next Year
- CELC N/A
- BGR N/A
- P/E Ratio
- CELC N/A
- BGR $18.97
- Revenue Growth
- CELC N/A
- BGR N/A
- 52 Week Low
- CELC $7.58
- BGR $11.38
- 52 Week High
- CELC $19.77
- BGR $13.37
- Technical
- Relative Strength Index (RSI)
- CELC 46.58
- BGR 50.90
- Support Level
- CELC $9.64
- BGR $12.29
- Resistance Level
- CELC $10.80
- BGR $12.64
- Average True Range (ATR)
- CELC 0.66
- BGR 0.20
- MACD
- CELC -0.06
- BGR 0.06
- Stochastic Oscillator
- CELC 25.25
- BGR 74.55
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About BGR BlackRock Energy and Resources Trust
BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.